Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
نویسندگان
چکیده
Agnès Lillo-Le Louët1; Martine Wolf2; Lilia Soufir3; Arnaud Galbois4,5,6; Anne-Sylvie Dumenil2; Georges Offenstadt4,5,7; Meyer-Michel Samama8, 9 1AP-HP, European Hospital Georges Pompidou, Paris, France; 2AP-HP, Antoine Béclère Hospital, Clamart, France; 3Saint-Joseph Hospital, Paris, France; 4 AP-HP, Hôpital Saint-Antoine, Service de Réanimation Médicale, Paris, France; 5UPMC, Univ Paris 06, Sorbonne Université, Paris, France; 6INSERM, UMR_S 938, CdR Saint-Antoine, Paris, France; 7INSERM, UMR_S 707, Paris, France; 8AP-HP, Broca – Cochin – Hôtel-Dieu Hospital Group, Paris, France; 9Biomnis Laboratory, Ivry-sur-Seine, France
منابع مشابه
Medicolegal Aspects of Life-Threatening Late Hemorrhage after Tonsillectomy: Report of Three Cases and Review of Articles
Aims: Secondary bleeding after tonsillectomy is an unavoidable. If it leads to a life-threatening event, it is likely to be associated with a malpractice claim against the surgeon. Very few reports have addressed this event from a medicolegal point of view. Therefore, the present report aimed to investigate litigations following secondary Post-tonsillectomy hemorrhage leading to death or life-t...
متن کاملO18: In Hospital Management of Child with Road Trauma
Trauma is the most common cause of mortality and morbidity in pediatric population. Caring for the injured child requires special knowledge, precise management, and scrupulous attention to details. All clinicians who are responsible for the care of a pediatric trauma patient, including pediatricians, pediatric emergency room clinicians, and trauma surgeons, must be familiar with every tenet of ...
متن کاملDabigatran etexilate - A novel oral anticoagulant for bleeding complications
Thromboembolic disease is a common cause of morbidity and mortality. Thrombin plays a key role in thrombotic events and thrombin inhibition represents a therapeutic event for thromboembolic events and has been identified as a target of therapy of its pivotal role in coagulation process. Anticoagulation is a major intervention for the management of arterial and venous thromboembolic events. Dabi...
متن کاملThe acute management of haemorrhage, surgery and overdose in patients receiving dabigatran
Dabigatran is an oral direct thrombin inhibitor (DTI) licensed for stroke prevention in atrial fibrillation and likely to be soon approved in Europe for treatment of venous thrombosis. Predictable pharmacokinetics and a reduced risk of intracranial haemorrhage do not negate the potential risk of haemorrhage. Unlike warfarin, there is no reversal agent and measurement of the anticoagulant effect...
متن کاملUse of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery
Purpose. To report the ability to remove serum dabigatran using continuous renal replacement therapy (CRRT) in a patient with life-threatening bleeding. Summary. A 77-year-old female with history of atrial fibrillation who takes dabigatran for stroke prevention presented with abdominal pain. Patient was found to have bleeding and possible mesenteric ischemia and was taken to the operating room ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Thrombosis and haemostasis
دوره 108 3 شماره
صفحات -
تاریخ انتشار 2012